Cancer Clinical Trial - BioNTech - MV-0715-CP-001.01

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT02672917

Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies. CONDITION(S): Pancreatic cancer

Drug

MVT-5873 + Mfolfirinox

Trial Type

Treatment

Condition

Pancreatic cancer

Keywords

MabVax | Pancreatic cancer | CA19-9 | BioNTech